FDA Drug Recalls

Recalls / Class II

Class IID-1542-2022

Product

Ampicillin for Injection, USP, 2 grams/vial NDC 67457-352-02, packaged in 10 x 2 g vials per carton NDC 67457-352-10, Rx only, Mylan Manufactured in India for: Mylan Institutional LLC Rockford, IL 61103 U.S.A

Affected lot / code info
Lot 7105130, exp 9/2023

Why it was recalled

Presence of Particulate Matter: A complaint was received for the presence of a single strand of hair in one vial.

Recalling firm

Firm
Viatris Inc
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
1000 Mylan Blvd, N/A, Canonsburg, Pennsylvania 15317-5853

Distribution

Quantity
3,931 cartons
Distribution pattern
Nationwide in the USA

Timeline

Recall initiated
2022-09-21
FDA classified
2022-09-23
Posted by FDA
2022-10-05
Terminated
2023-10-31
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1542-2022. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.